Vertex Pharmaceuticals (VRTX) Goodwill & Intangibles (2009 - 2026)

Vertex Pharmaceuticals has reported Goodwill & Intangibles for 18 years, with the latest figure at $1.5 billion in Q2 2026.

• On a quarterly basis, Goodwill & Intangibles fell 1.49% year-over-year to $1.5 billion in Q2 2026; TTM through Jun 2026 was $1.5 billion, a 1.49% decrease from a year earlier, with the FY2025 full-year figure at $1.5 billion, down 21.48% from the prior year.
• Goodwill & Intangibles was $1.5 billion for Q2 2026 at Vertex Pharmaceuticals, roughly flat from $1.5 billion in the prior quarter.
• The five-year high for Goodwill & Intangibles was $1.9 billion in Q4 2023, with the low at $1.4 billion in Q2 2022.
• Average Goodwill & Intangibles over 5 years is $1.7 billion, with a median of $1.7 billion recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Goodwill & Intangibles grew 21.77% in 2023, then decreased 21.48% in 2025.
• Over 5 years, Goodwill & Intangibles stood at $1.7 billion in 2022, then climbed by 13.87% to $1.9 billion in 2023, then declined by 0.72% to $1.9 billion in 2024, then fell by 21.48% to $1.5 billion in 2025, then retreated by 0.75% to $1.5 billion in 2026.
• The last three Goodwill & Intangibles figures came in at $1.5 billion (Q2 2026), $1.5 billion (Q1 2026), and $1.5 billion (Q4 2025), per Business Quant data.